Swiss Society of Medical Oncology
Società Svizzera di Oncologia Medica
Société Suisse d’Oncologie Médicale
Schweizerische Gesellschaft für Medizinische Onkologie
c/o Pro Medicus GmbH
Minervastrasse 23/25
CH-8032 Zürich
T. +41 (0)43 266 99 12
info@sgmo.ch
This site uses cookies. By continuing to use the site, you agree to the use of cookies.
ACCEPT SETTINGSSettingsData protectionWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Datenschutz
SPAP prolonged until the end of 2027
We are pleased to announce that, on the initiative of SSMO, all current partner companies have agreed to an prolongation of the Swiss Patient Access Program (SPAP). This important program […]
SSMO statement on Lunsumio
The SSMO takes note of this unprecedented incident with concern. Although follicular lymphoma is a relatively rare form of cancer affecting relatively few patients, it nevertheless raises an important question: […]
SOHC 2025
19 – 21 November 2025 Congress Center Basel “Bridging the gaps in patient care” The SOHC is a unique opportunity to meet for personal interaction and a joint learning experience […]
DGHO Jahrestagung 2025 in Köln
Die Planung des Kongresses schreitet voran und die ersten Meilensteine sind erreicht. Freuen Sie sich auf gute Vorträge, innovative Formate und den Austausch mit Expert:innen. Vorprogramm online Erste Einblicke in […]
SPAP – A contribution to alleviating hardship cases according to Article 71a-d KVV
Access to medication and reimbursement of so-called individual case assessments (Art. 71 a-d KVV) for chronic and fatal illnesses is unique in Switzerland. Nevertheless, patients repeatedly fall through the cracks […]
Third pharmaceutical company at SPAP
On 1 January 2025, iQone will become the third pharmaceutical company to join the Swiss Patient Access Program (SPAP). So far, Roche and AstraZeneca are partner companies of SPAP. As […]
Current status of SPAP – Swiss Patient Access Program
Current status of the SPAP project (Swiss Patient Access Program): The project has now been running for a little over a year The processes have been thoroughly tested and are […]
SGMO Curriculum – the new continuous education series in medical oncology
The SSMO, together with its cooperation partners, the Forum for Medical Education (FOMF) and the Swiss Academy of Medical Oncology (SAMO), offers a structured, application-oriented training programme for oncologists who […]
KVV/KLV revision – implementation difficulties: statement to the FDIA
The following letter was sent today (16 September 2024) to the FDIA by SSMO, SSH, SPOG, SAKK, the Swiss Cancer League, unimedsuisse and kosek: Herausforderungen bei der Anwendung von Artikel […]
OHI/OHCS revision – practical implications for doctors
On 1 January 2024, a comprehensive revision of the Ordinance on Health Insurance (OHI) and the FDHA Ordinance on Health Care Services (OHCS) came into force. On behalf of the […]